18F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 8, 2013, Pages 1190-1196

  Bonfiglioli, Rachele ^a   Nanni, Cristina ^a   Morigi, Joshua James ^a   Graziosi, Maddalena ^a   Trapani, Filippo ^a   Bartoletti, Michele ^a   Tumietto, Fabio ^a   Ambrosini, Valentina ^a   Ferretti, Alice ^b   Rubello, Domenico ^b   Rapezzi, Claudio ^a   Viale, Pier Luigi ^a   Fanti, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ospedale S Maria della Misericordia   (Italy)

Author keywords

18F FDG PET CT; Endocarditis; Extracardiac infection; Metastatic septic embolism

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; PROCALCITONIN;

ABSCESS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BRAIN EMBOLISM; BRAIN INFARCTION; CARDIAC PATIENT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; EMBOLISM; HEART SURGERY; HUMAN; INTERVERTEBRAL DISK DEGENERATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; OSTEOCHONDRITIS; OSTEOMYELITIS; PROSTHETIC VALVE ENDOCARDITIS; SEPSIS; SPLEEN INFARCTION; WHOLE BODY IMAGING; ADULT; AGED; COMPUTER ASSISTED TOMOGRAPHY; ENDOCARDITIS, BACTERIAL; FEMALE; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; EMBOLISM; ENDOCARDITIS, BACTERIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; SEPSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84879897523     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2426-7     Document Type: Article

References (30)

1. Ak I, Stokkel MP, Pauwels EK. Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours. J Cancer Res Clin Oncol 2000;126(10):560-74.
2. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000;30(3):150-85.
3. Coleman RE. Clinical PET in oncology. Clin Positron Imaging 1998;1(1):15-30.
4. Delbeke D. Oncological applications of FDG PET imaging. J Nucl Med 1999;40(10):1706-15.
5. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995;36(7):1301-6.
6. Metser U, Even-Sapir E. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med 2007;37(3):206-22.
7. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 2007;48(1):35-45.
8. Vos FJ, Bleeker-Rovers CP, Corstens FH, Kullberg BJ, Oyen WJ. FDG-PET for imaging of non-osseous infection and inflammation. Q J Nucl Med Mol Imaging 2006;50(2):121-30.
9. Reeps C, Essler M, Pelisek J, Seidl S, Eckstein HH, Krause BJ. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg 2008;48(2):417-23. discussion 424.
10. Hautzel H, Sander O, Heinzel A, Schneider M, Müller HW. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med 2008;49(7):1107-13.
11. Walker RC, Jones-Jackson LB, Martin W, Habibian MR, Delbeke D. New imaging tools for the diagnosis of infection. Future Microbiol 2007;2(5):527-54.
12. De Winter F, Vogelaers D, Gemmel F, Dierckx RA. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis 2002;21(4):247-57.
13. Pauwels EK, Sturm EJ, Bombardieri E, Cleton FJ, Stokkel MP. Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 2000;126(10):549-59.
14. Belhocine T, Spaepen K, Dusart M, Castaigne C, Muylle K, Bourgeois P, et al. 18FDG PET in oncology: the best and the worst. Int J Oncol 2006;28(5):1249-61.
15. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33(11):1972-80.
16. Weisdorf DJ, Craddock PR, Jacob HS. Glycogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis. Blood 1982;60(4):888-93.
17. Schelbert HR, Hoh CK, Royal HD, Brown M, Dahlbom MN, Dehdashti F, et al. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine. J Nucl Med 1998;39(7):1302-5.
18. Bing RJ. Cardiac metabolism. Physiol Rev 1965;45:171-213.
19. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 1974;36:413-59.
20. Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989;32(3):217-38.
21. Bertagna F, Bisleri G, Motta F, Merli G, Cossalter E, Lucchini S, et al. Possible role of F18-FDG-PET/CT in the diagnosis of endocarditis: preliminary evidence from a review of the literature. Int J Cardiovasc Imaging 2012;28(6):1417-25.
22. Knuuti J, Schelbert HR, Bax JJ. The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction. Eur J Nucl Med Mol Imaging 2002;29(9):1257-66.
23. Fukuchi K, Ohta H, Matsumura K, Ishida Y. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies. Br J Radiol 2007;80(949):3-11.
24. Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol 2008;190(2):W151-6.
25. Rogers IS, Nasir K, Figueroa AL, Cury RC, Hoffmann U, Vermylen DA, et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging 2010;3(4):388-97.
26. Büther F, Dawood M, Stegger L, Wübbeling F, Schäfers M, Schober O, et al. List mode-driven cardiac and respiratory gating in PET. J Nucl Med 2009;50(5):674-81.
27. Vind SH, Hess S. Possible role of PET/CT in infective endocarditis. J Nucl Cardiol 2010;17(3):516-9.
28. Van Riet J, Hill EE, Gheysens O, Dymarkowski S, Herregods MC, Herijgers P, et al. (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging 2010;37(6):1189-97.
29. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. ESC Committee for Practice Guidelines. Eur Heart J 2009;30(19):2369-413.
30. Alavi A, Saboury B, Basu S. Imaging the infected heart. Sci Transl Med 2011;3(99):99fs3.